��ƽ��

JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
About Us
News

News

Learn about key ��ƽ�� news by reading press releases, as well as mentions of us by external media outlets.

��ƽ�� Technologies Announces FDA De Novo Classification for Its EasySep™ CD138 Positive Selection Kit to Support Cancer Diagnostic Tests

03/26/2024
��ƽ�� Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies Company

02/29/2024
��ƽ�� Is a 2024 Biotalent Canada I.D.E.A.L. Bioscience Employer

02/15/2024
Dr. Allen Eaves Featured on BC Legends with Carole Taylor

02/01/2024
��ƽ�� Technologies Announces Acquisition of Propagenix Inc.

01/19/2024
World-Renowned Researchers Drs. Connie and Allen Eaves’ 50-Year Legacy Honoured with Dedicated BC Cancer Clinical Service Lab

12/04/2023
��ƽ�� Technologies Wins a Canada’s Most Admired™ Corporate Cultures of 2023 Award

11/23/2023
��ƽ�� Technologies Expands into Toronto’s MaRS Centre, Grows North American Presence

10/26/2023
��ƽ�� Technologies Releases “Toward Sustainable Science” Report

10/11/2023
��ƽ�� Technologies Partners with Science World to Empower Girls Pursuing Science-related Careers

09/25/2023
Looking Back on 30 Years in Biotech

07/17/2023
��ƽ�� Technologies Celebrates 30 Years with Unprecedented Annual Growth

07/12/2023